S.4355

Drug Deal Disclosure Act

Introduced·4/21/26
Introduced

S. 4355

Introduced in Senate · May 1, 2026

April 21, 2026

Mr. Wyden (for himself, Mr. Welch, Ms. Warren, Mr. Gallego, Mr. Merkley, Mr. Luján, Ms. Baldwin, Mr. Whitehouse, Mr. Kelly, Mr. Sanders, Mr. Warner, Ms. Smith, Ms. Hassan, Ms. Cortez Masto, Mr. Bennet, Mr. Warnock, Ms. Hirono, and Ms. Cantwell) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Drug Deal Disclosure Act”.